Dr. K.V. Babu, an ophthalmologist from Kannur, Kerala, has significantly impacted India's medical landscape through his persistent advocacy for transparency and consumer rights.
Advocating for Transparency in the National Medical Commission
Dr. Babu's commitment to transparency led him to challenge the National Medical Commission (NMC), India's top medical education regulator, to disclose its members' assets. Despite a statutory requirement for such declarations, the NMC had not complied since its establishment in 2020. Dr. Babu filed multiple Right to Information (RTI) applications and, facing resistance, escalated the matter to the Prime Minister's Office (PMO). His efforts resulted in the NMC publicly declaring the assets of its chairperson, presidents, and full-time members for the first time, marking a significant step toward transparency in medical governance.
Combating Misleading Medical Advertisements
Dr. Babu has also been active in protecting consumers from misleading medical advertisements. He filed a complaint against Divya Pharmacy, associated with Patanjali Ayurved, for promoting products with unverified health claims. This led to a Kerala court summoning Baba Ramdev and Acharya Balkrishna to address allegations of deceptive advertising.
In another instance, Dr. Babu's complaint prompted the PMO to direct the Health Ministry to expedite amendments to the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. The proposed changes aim to broaden the act's scope, introducing stricter regulations against misleading advertisements, including those related to Ayush medicines.
Ensuring Safe Medical Practices
Concerned about patient safety, Dr. Babu took action against a Rajasthan-based company manufacturing homeopathic tablets labeled as 'Insulin.' He argued that such labeling could mislead patients into substituting prescribed insulin injections with these tablets, potentially leading to uncontrolled diabetes. His complaint resulted in the cancellation of the company's manufacturing license for the product, preventing possible health risks.
Dr. Babu's unwavering dedication to transparency, consumer protection, and patient safety has led to significant reforms in India's medical sector, highlighting the profound impact one individual's commitment can have on public health and governance.
ഡോ. സജ്ന സഈദ്
കോഴിക്കോട്
ഡെങ്കിപ്പനിക്ക് പുറമെ എച്ച്1 എൻ 1, എലിപ്പനി എന്നിവയും റിപ്പോർട്ട് ചെയ്യപ്പെടുന്ന സാഹചര്യത്തിൽ പൊതുജനങ്ങൾ ജാഗ്രത പാലിക്കണമെന്ന്ആരോഗ്യ വകുപ്പ് അറിയിച്ചു.
The study, published in Eco-Environment & Health on 4 March 2024 (DOI: 10.1016/j.eehl.2024.02.004), has highlighted the significant cardiotoxic effects of 2,6-DHNPs on zebrafish embryos, which serve as a model for potential human health risks.
Dr Sankar Mahadevan
അസിസ്റ്റന്റ് പൊഫസ്സർ, ഡിപ്പാർട്മെന്റ് ഓഫ് ജനറൽ മെഡിസിൻ, ഗവണ്മെന്റ് മെഡിക്കൽ കോളേജ്, കോഴിക്കോട്
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, etc.